FEB 22, 2021 8:09 PM PST

Screening Macrocyclic Peptides

WRITTEN BY: Nouran Amin

Macrocyclic peptides are promising for pharmaceuticals for cancer—however, screening for them is challenging. Findings were published in the journal Angewandte Chemie.

"Well-established screening approaches often require highly expensive instrumentation and appropriate training," says Ashram Brik from the Technion-Israel Institute of Technology, Israel, who is set up to develop alternative strategies.

Learn more about peptide based-drugs:

"For example, we subjected the peptides to chemistries such as alkylation arylation, oxidation and dimerization, the first step to make polycyclic peptides," Brik said. "Polycyclic peptides have added value crucial to be considered as drug candidates." Scientists assume that cyclization makes the peptides more stable than their open analogues, and their compact shapes help them to enter cells more easily.

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
DEC 27, 2020
Drug Discovery & Development
Attacking Mitochondria in Tumors
DEC 27, 2020
Attacking Mitochondria in Tumors
Researchers found that attacking a cell’s mitochondria can starve cancer cells. The study involves a possible ther ...
FEB 07, 2021
Drug Discovery & Development
Beta-Blockers Can Repair Broken Blood Vessels
FEB 07, 2021
Beta-Blockers Can Repair Broken Blood Vessels
Propranolol is a drug that can treat infantile haemangiomas but was found to also treat a blood vessel condition that le ...
MAR 09, 2021
Cannabis Sciences
Top Benefits of Having Your Medical Marijuana Card
MAR 09, 2021
Top Benefits of Having Your Medical Marijuana Card
With the use of medicinal marijuana booming, estimated at almost 4.5 million patients in 2020, it’s time to talk a ...
MAR 12, 2021
Drug Discovery & Development
Drug Starves Melanoma Tumors
MAR 12, 2021
Drug Starves Melanoma Tumors
Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified a drug candidate that blocks the uptake ...
APR 01, 2021
Immunology
Tumor-Killing 101: Vaccine Trains Immune Cells to Keep Skin Cancer at Bay
APR 01, 2021
Tumor-Killing 101: Vaccine Trains Immune Cells to Keep Skin Cancer at Bay
Cancer researchers have developed a therapeutic vaccine for melanoma, a deadly form of skin cancer. Instead of protectin ...
APR 10, 2021
Drug Discovery & Development
How New ADHD Drug for Children Differs from Adderall
APR 10, 2021
How New ADHD Drug for Children Differs from Adderall
Over 1 in 10 children in the US aged between 5 and 17 have been diagnosed with attention deficit hyperactivity ...
Loading Comments...